Close Menu

NEW YORK (GenomeWeb) – BioGx announced today that Switzerland's AxonLab will distribute assay products from BioGx's European-based subsidiary in multiple European countries.

As part of the multi-year collaboration, AxonLab will work with a Netherlands-based subsidiary of Birmingham, Alabama-based BioGx to distribute its products to the majority of Central Europe, including Austria, Belgium, the Czech Republic, Germany, Slovenia, Switzerland, and Croatia. Distribution will include all of BioGx's CE-IVD product line, as well as laboratory-use-only products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.